trypf.png
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Charting Its Own Course in Psychedelic Space
June 30, 2021 08:30 ET | Tryp Therapeutics Inc.
NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...
QMI-Logo-Long-1000px.jpg
Global Biologics Safety Testing Market Size to Grow at a CAGR of 12.3% from 2021 to 2030
June 15, 2021 06:30 ET | Quince Market Insights
Pune, India, June 15, 2021 (GLOBE NEWSWIRE) -- The global biologics safety testing market has been estimated to reach USD 3.0 billion in 2021 and is projected to grow at a CAGR of 12.3% during the...
visiongain Logo.png
CNS Therapeutics market size worth US$ 180.3 billion by 2031. Visiongain Research Inc.
June 09, 2021 09:00 ET | Visiongain Ltd
Visiongain has published a new report on “CNS Therapeutics Market Forecast, 2021-2031”. Forecasts by Disease (Neurovascular Disease, Trauma, Mental Health, Degenerative, Others), End Use (Hospitals,...
arbor-logo-tree-color.png
Arbor Biotechnologies to Present at the Evercore ISI GenomeRx Emerging Therapeutics Conference and the Jefferies Virtual Healthcare Conference
June 02, 2021 08:00 ET | Arbor Biotechnologies Inc
CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company discovering and developing the next generation of genetic medicines, announced today...
trypf.png
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Brings Best-in-Class Team to Psychedelics Development
May 21, 2021 08:30 ET | Tryp Therapeutics Inc.
NEW YORK, May 21, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) announces the availability of a broadcast titled, “Wall Street Unicorns in Process of...
trypf.png
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Bringing Diversified Pipeline to Psychedelic Revival
May 19, 2021 08:30 ET | Tryp Therapeutics Inc.
NEW YORK, May 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...
Codex DNA Releases Long Gene Fragment Cloning On The BioXp™ System
May 04, 2021 10:00 ET | Codex
San Diego, CA, May 04, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc., creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, announced the...
Artelo LOGO.jpg
Artelo Biosciences, Inc. to Present at the Q1 Virtual Investor Summit on March 23rd
March 11, 2021 07:10 ET | Artelo Biosciences, Inc.
LA JOLLA, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate...
AIM ImmunoTech LOGO.jpg
AIM ImmunoTech to Present at the Q1 Virtual Investor Summit on March 24th
March 11, 2021 07:00 ET | AIM ImmunoTech Inc.
OCALA, Fla., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech, will be...
Codex DNA Releases World’s First Synthetic Genomes for Emerging SARS-CoV-2 Variants
March 10, 2021 10:00 ET | Codex
San Diego, March 10, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc., today announced the release of the world’s first full-length synthetic genomes for two emerging variants of the SARS-CoV-2 virus. The...